ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,474,340, issued on Nov. 18, was assigned to Nant Holdings IP LLC (Culver City, Calif.).
"Validation of neoepitope presentation" was invented by Kayvan Niazi (Culver City, Calif.) and Nicholas J. Witchey (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods for predicting MHC presentation of a neoepitope of a tumor or for predicting an immune response against an MHC presented neoepitope of a tumor are disclosed. The methods use sequence information of the neoepitope."
The patent was filed on Sept. 24, 2018, under Application No. 16/647,277.
*For further information, including images, charts and tables, please visit: ht...